Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
item.page.accessRights
item.page.other
item.page.references
Abstract
Background: The New Approach Rivaroxaban Inhibition of Factor Xa in a Global Trial vs. ASA to Prevent Embolism in Embolic Stroke of Undetermined Source (NAVIGATE-ESUS) trial is a randomized phase-III ...
Description
Author Manuscript
item.page.coverage.spatial
item.page.sponsorship
Citation
Kasner, S. E., Lavados, P., Sharma, M., Wang, Y., Wang, Y., Dávalos, A., Shamalov, N., Cunha, L., Lindgren, A., Mikulik, R., Arauz, A., Lang, W., Czlonkowska, A., Eckstein, J., Gagliardi, R., Amarenco, P., Ameriso, S. F., Tatlisumak, T., Veltkamp, R., Hankey, G. J., … NAVIGATE ESUS Steering Committee and Investigators (2018). Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 27(6), 1673–1682. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.01.027
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
1 0,8 0,5 0,3 0
Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026Marzo 2026